|
|
 |
|
|
 |
|
The Asian-Pacific Research Foundation for Infectious Diseases
(ARFID) was founded to initiate and support collaborative
research on infectious diseases and antimicrobial agents.
It was originally conceived as an official supporting
system for international research activities by the Asian
Network for Surveillance of Resistant Pathogens (ANSORP).
From ANSORP activities, the process to establish ARFID
took place in three phases. |
 |
|
| This
phase started with the organization of ANSORP
as of January 1996 by Professor Jae-Hoon Song
(Korea) and Asian investigators in 11 countries.
ANSORP, Asia's first multinational collaborative
study group for research on infectious diseases,
has been carrying out multinational surveillance
studies and related international activities
since 1996. |
 June
1996 |
| The
first ANSORP project, which was the
surveillance of pneumococcal resistance
in the Asian region, was launched. The
study was successfully completed at
the end of 1997. |
| April
1997 |
| The
1st International Symposium on Antimicrobial
Resistance and the 1st Annual Meeting
of ANSORP took place at the Samsung
Medical Center in Seoul, Korea. This
event was the first international conference
focusing on antimicrobial resistance
in the Asian region. |
| January
1998 |
| The
second project by ANSORP carried out
from January 1998 to April 1999 was
the study on carriage of antibiotic-resistant
pneumococci in Asian children. ANSORP
centers were extended to Manila (Philippines)
and Riyadh (Saudi Arabia). |
| May
1999 |
| The
2nd International Symposium on Antimicrobial
Resistance and the 2nd Annual Meeting
of ANSORP took place in Seoul, Korea
with more topics and invited speakers.
A total of 500 audiences could get the
state-of-the-art information on antimicrobial
resistance. |
|
|
|
 |
|
| Based
on successful collaboration for 4 years, ANSORP
started to plan for developing the research
foundation which could coordinate and support
research activities more effectively with
regard to planning, financial and administrative
support, and communications. A permanent property
of the foundation was endowed by unconditional
grant from LG Chemical, Yuhan Corporation
and Choongwae Pharma Corporation. The Governing
Board of Trustees was composed of 8 members.
A formal proposal to establish ARFID was submitted
to the Ministry of Health and Welfare in Korea
in October 1999 and was approved as of December
8th, 1999. |
|
|
 |
|
The
Asian-Pacific Research Foundation for Infectious
Diseases (ARFID) was officially launched as
of January 6th, 2000 with the first Board
meeting. ARFID appointed members of the International
Advisory Board to guide the operations by
the foundation. ARFID established ABB and
IDRI in Seoul, Korea to promote the research
activities in the region in 1999.
Since 1997, ISAAR has been contributing to
gather the relevant data and information on
various issues of antimicrobial resistance
and infectious diseases with regard to the
updated epidemiology, mechanism of resistance,
new diagnostic methods, therapeutic strategies,
and preventive measures. ISAAR became the
most representative international meeting
on infectious diseases and antimicrobial agents/resistance
in the Asian-Pacific region. |
|
|
|
|
Visions and Functions
